Research

Every report, newest first.

Company profiles, earnings reports, pre-earnings briefings and news — across all 6,500 companies we cover.

Company Profiles
Company Profile
SoundThinking’s Second Act: Can ShotSpotter’s Data Moat Fund a Broader Public Safety Platform?
On a cold night in Pueblo, Colorado, a burst of gunfire triggers an automated ShotSpotter alert. Seconds later, an autonomous drone is in the air, streaming vid…
SSTI Jun 18, 2026 Company Profile
The Children’s Place at a Crossroads: Can a Digital-First Pivot Outrun Debt and Decline?
By the end of fiscal 2025, The Children’s Place looked stretched in two directions at once. On one side: negative equity of $54.2 million, more than half a bill…
PLCE Jun 18, 2026 Company Profile
Red Robin’s high-wire reset: inside Dave Pace’s bid to turn a leveraged burger icon into a cash generator
On Red Robin’s Q1 2026 call, CEO Dave Pace could point to the chain’s strongest traffic since early 2023 and its best first-quarter restaurant margins in five y…
RRGB Jun 18, 2026 Company Profile
CAMP4 Therapeutics under the CAMP ticker: separating a new biotech from an old telematics story
Pull up CAMP on a data terminal and the picture looks puzzling: tiny quarterly revenues, heavy losses, and earnings calls about connected cars. Yet the name on …
CAMP Jun 18, 2026 Company Profile
Full House Resorts weighs a $300 million bet on Illinois as leverage climbs
On an early 2026 earnings call, with just $41 million of liquidity and more than $530 million of debt, Full House Resorts’ executives told investors they planne…
FLL Jun 18, 2026 Company Profile
Karyopharm at a crossroads: can selinexor and SENTRY turn a single‑asset bet into a durable oncology business?
On a single earnings call this spring, Karyopharm Therapeutics looked like two different companies: a late-stage oncology player unveiling Phase III data that c…
KPTI Jun 18, 2026 Company Profile
Hain Celestial at a crossroads: can Alison Lewis turn a carved-up portfolio into a cash generator?
A decade after investors embraced Hain Celestial as a pure-play bet on natural and organic foods, the company is now selling a fifth of its sales, shrinking to …
HAIN Jun 18, 2026 Company Profile
Seres Therapeutics’ microbiome pivot: can SER-155 outrun the cash clock?
On Seres Therapeutics’ Q3 2025 earnings call, Co-CEO and CFO Marella Thorell stressed that the company’s $8.2 million profit was entirely the product of a $27.2…
MCRB Jun 18, 2026 Company Profile
Signature Bank's Deliberate Shrinkage: Walking Away From Growth to Save the Franchise
On December 6, 2022, Joseph DePaolo told an industry conference that Signature Bank would do something unusual for a fast-growing bank: it would deliberately sh…
SBNY Jun 18, 2026 Company Profile
Sportsman's Warehouse Posts First Positive Comps Since 2020, but the Real Story Is What It Took to Get There
After five years of declining comparable store sales, Sportsman's Warehouse eked out 1% growth in fiscal 2025, the first payoff of a painful strategic narrowing…
SPWH Jun 18, 2026 Company Profile
Sequans’ IoT bet meets a Bitcoin balance sheet: can the runway last to 2026 breakeven?
On Sequans’ Q1 2026 call, CEO Georges Karam described an unusual position: by June 1, he expects the small French IoT chipmaker to be almost debt-free and still…
SQNS May 26, 2026